⌘K

Login Start Free

Home/Insiders/Murphy Matthew B.

MM

SEC Insider//CIK 0001865778

Murphy Matthew B.

CIK 00018657781 companySEATTLE, WA

Transactions

11

Companies

1

Filings

10

CIK

0001865778

Recent Transactions

11 trades

Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2026-03-02+160,000→ 160,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2025-09-04$0.64/sh+20,000→ 74,140 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2025-03-03+160,000→ 160,000 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2024-03-01+160,000→ 160,000 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2023-02-27+160,000→ 160,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2022-08-15$2.84/sh+7,500→ 54,140 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2022-08-12$2.85/sh+2,500→ 46,640 total
Award
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2022-05-12$3.28/sh+10,000→ 44,140 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2022-02-25+140,000→ 140,000 total
Purchase
Nautilus Biotechnology, Inc.$NAUT
Common Stock
2021-08-13$7.56/sh+5,000→ 34,140 total
Award
Nautilus Biotechnology, Inc.$NAUT
Stock Option (Right to Buy)
2021-06-14+326,526→ 326,526 total

Companies

1

Nautilus Biotechnology, Inc.
General Counsel
$NAUT

Recent Filings

10

Address

C/O NAUTILUS BIOTECHNOLOGY, INC. 2701 EASTLAKE AVENUE EAST

SEATTLE, WA, 98102

View on SEC.gov